(PharmaNewsWire.Com, December 26, 2017 ) According to the report North America Therapeutic Vaccines Market, published by Market Data Forecast, the market is projected to reach USD 1.83 billion by 2021, at a CAGR of 30.77% from 2016 to 2021.
A Vaccine is a biological preparation that enables active acquired immunity to a specific disease. It contains an agent similar to a disease causing micro-organism, generally prepared from a killed of weaken form of the microbe, its toxins or one of its surface proteins.
The agent then stimulates the body to prepare an immune system recognizing the agent as threat and destroying it. Later it will be able to recognize and destroy any of those microbes that it encounters in the future.
Therapeutic Vaccines Market: Drivers & Restraints Factors fuelling the growth of market are increasing funding from governments for vaccine development and setting up vaccinating camps, increasing prevalence of diseases, initiatives from NGOs and technological advancements. However, huge capital expenditures, expensive costs associated with treatments and stringent regulations are the factors hindering the growth of market.
By Disease Type • Autoimmune Disease Vaccines • Cancer Vaccines o Multikine o PR1 Peptide o TroVax o CYT004-MelQbG10 • Neurological Disease Vaccines o ACC-001 o CAD 106 o Parkinson’s Disease Vaccine o Alzheimer’s Disease Vaccine • Infectious Disease Vaccines o Hepatitis C o HIV/AIDS o Other Infectious Diseases
Therapeutic Vaccines Market: Overview Currently, in pipeline several approaches are being developed in order to boost the immune response to various infectious and cancerous cells. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years. With USA and Canada averaging around 300 people diagnosed per 100,000 the need for therapeutic vaccines became imminent in the region. The field of cancer immunotherapy received an important boost with the FDA’s approval of the first therapeutic cancer vaccine, which surely results in the positive growth of the market.
Therapeutic Vaccines Market: Region-wise Outlook Geographically this market in analysed into regions of Canada and United States of America. United States of America hold the major share owing to its rapid adoption rate and increasing population. USA is also expected to grow the fastest due to increasing public awareness and growing adoption rate. North America is expected to grow with highest CAGR in this forecasted period.
Key Questions Answered • What is the current and future Therapeutic Vaccines Market outlook in North America? What trends are affecting the market? • What is the competitive landscape and market share of major players in the Therapeutic Vaccines Market space in North America? • What are the key, high growth markets that Therapeutic Vaccines Market manufacturers should expand into? Which market segments are growing the fastest? • What are the unmet needs with the Therapeutic Vaccines currently on the market? How will emerging technologies fulfil these unmet needs? • What is patient perception and market outlook of Therapeutic Vaccines? • What are the challenges and barriers that have hindered widespread adoption of Therapeutic Vaccines?
Therapeutic Vaccines Market: Key Players Some of the key players influencing the North America preventive vaccine market are GlaxoSmithKline, plc., Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.
Reasons to buy Therapeutic Vaccines Market Report: • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering • Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics • Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses • A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies • Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
